Onvansertib combined with standard care showed up to 49% confirmed ORR in RAS-mutated colorectal cancer, with early signs of PFS benefit.

Gain insights into Watsco, Inc.'s Q2 2025 performance, including record margins, tech-driven growth, and its strategic focus on overcoming market ...

Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), ...

Data analytics firm Verisk said on Wednesday it will buy AccuLynx, which makes software for roofing contractors, for $2.35 ...

A spokesperson for the Department of Health and Human Services confirmed that Dr. Vinay Prasad, who led the FDA’s Center for ...

The abrupt exit of the former CBER director, who quickly made his mark at the agency with several high-profile and ...

Customer-Focused, High-Performance Pest Control Platform Begins New Era of Growth with Gridiron Capital OREM, Utah, July 30, 2025 /PRNewswire/ -- Greenix ...

Data analytics provider Verisk is acquiring SaaS platform AccuLynx for $2.35bn in cash, the company said in a statement. The ...

Walmart is latching on to the growing interest in soccer, embarking on a multi-year partnership with Major League Soccer (MLS ...

But while many analysts presented a bullish case for the company's turnaround, not all investors are sold on Niccol and his ...

Verisk, a data analytics and technology provider to the insurance and energy industries, has entered into a definitive ...

Vinay Prasad, M.D., has left the FDA, less than three months into the role as director of the Center for Biologics Evaluation ...